BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22359293)

  • 1. Epigenetics of colon cancer.
    Khare S; Verma M
    Methods Mol Biol; 2012; 863():177-85. PubMed ID: 22359293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
    Derks S; Bosch LJ; Niessen HE; Moerkerk PT; van den Bosch SM; Carvalho B; Mongera S; Voncken JW; Meijer GA; de Bruïne AP; Herman JG; van Engeland M
    Carcinogenesis; 2009 Jun; 30(6):1041-8. PubMed ID: 19329758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic regulation of human retinoblastoma.
    Singh U; Malik MA; Goswami S; Shukla S; Kaur J
    Tumour Biol; 2016 Nov; 37(11):14427-14441. PubMed ID: 27639385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Methylation in Colorectal Cancer.
    Kaur S; Lotsari-Salomaa JE; Seppänen-Kaijansinkko R; Peltomäki P
    Adv Exp Med Biol; 2016; 937():109-22. PubMed ID: 27573897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management.
    Deka D; Scarpa M; Das A; Pathak S; Banerjee A
    Endocr Metab Immune Disord Drug Targets; 2021; 21(10):1882-1894. PubMed ID: 33605866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Intricate Interplay between Epigenetic Events, Alternative Splicing and Noncoding RNA Deregulation in Colorectal Cancer.
    Amirkhah R; Naderi-Meshkin H; Shah JS; Dunne PD; Schmitz U
    Cells; 2019 Aug; 8(8):. PubMed ID: 31430887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focus on genetic and epigenetic events of colorectal cancer pathogenesis: implications for molecular diagnosis.
    Zoratto F; Rossi L; Verrico M; Papa A; Basso E; Zullo A; Tomao L; Romiti A; Lo Russo G; Tomao S
    Tumour Biol; 2014 Jul; 35(7):6195-206. PubMed ID: 25051912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of microRNA expression in colorectal cancer.
    Bandres E; Agirre X; Bitarte N; Ramirez N; Zarate R; Roman-Gomez J; Prosper F; Garcia-Foncillas J
    Int J Cancer; 2009 Dec; 125(11):2737-43. PubMed ID: 19521961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic aberrations during oncogenesis.
    Hatziapostolou M; Iliopoulos D
    Cell Mol Life Sci; 2011 May; 68(10):1681-702. PubMed ID: 21249513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetics of colorectal cancer.
    Migheli F; Migliore L
    Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer.
    Katzenmaier EM; Kloor M; Gabius HJ; Gebert J; Kopitz J
    IUBMB Life; 2017 Dec; 69(12):962-970. PubMed ID: 29098769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and promoter methylation status of hMLH1, MGMT, APC, and CDH1 genes in patients with colon adenocarcinoma.
    Michailidi C; Theocharis S; Tsourouflis G; Pletsa V; Kouraklis G; Patsouris E; Papavassiliou AG; Troungos C
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1599-605. PubMed ID: 25908636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic and epigenetic instability in colorectal cancer pathogenesis.
    Grady WM; Carethers JM
    Gastroenterology; 2008 Oct; 135(4):1079-99. PubMed ID: 18773902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
    Savio AJ; Bapat B
    Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CpG island hypermethylation of tumor suppressor microRNAs in human cancer.
    Lujambio A; Esteller M
    Cell Cycle; 2007 Jun; 6(12):1455-9. PubMed ID: 17581274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation alterations in multiple myeloma as a model for epigenetic changes in cancer.
    Sharma A; Heuck CJ; Fazzari MJ; Mehta J; Singhal S; Greally JM; Verma A
    Wiley Interdiscip Rev Syst Biol Med; 2010; 2(6):654-69. PubMed ID: 20890963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.
    Irizarry RA; Ladd-Acosta C; Wen B; Wu Z; Montano C; Onyango P; Cui H; Gabo K; Rongione M; Webster M; Ji H; Potash J; Sabunciyan S; Feinberg AP
    Nat Genet; 2009 Feb; 41(2):178-186. PubMed ID: 19151715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations in colorectal cancer are associated with the epigenetic modifications.
    Lei H; Tao K
    J Cell Mol Med; 2020 Oct; 24(20):11828-11836. PubMed ID: 32865336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell 'stemness' via the bone morphogenetic protein pathway.
    Kodach LL; Jacobs RJ; Voorneveld PW; Wildenberg ME; Verspaget HW; van Wezel T; Morreau H; Hommes DW; Peppelenbosch MP; van den Brink GR; Hardwick JC
    Gut; 2011 Nov; 60(11):1544-53. PubMed ID: 21551187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.